Clinical Trial: A Study to Assess the Effect of Povorcitinib on Digoxin, Rosuvastatin, and Metformin Pharmacokinetics When Administered Orally to Healthy Adult Participants

U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT06416800) titled 'A Study to Assess the Effect of Povorcitinib on Digoxin, Rosuvastatin, and Metformin Pharmacokinetics When Administered Orally to Healthy Adult Participants' on April 29.

Brief Summary: The purpose of this study is to Assess the Effect of Povorcitinib on Digoxin, Rosuvastatin, and Metformin Pharmacokinetics When Administered Orally to Healthy Adult Participants.

Study Type: Interventional

Condition: Healthy Participants

Intervention: * Drug: Digoxin

Oral; Tablet

* Drug: Rosuvastatin

Oral; Tablet

* Drug: Metformin

Oral; Tablet

* Drug: Povorcitinib

Oral; Tablet

Recruitment Status: Not Yet Recruiting

Published by HT Digital ...